2013

November19

Indiana Biosciences Research Institute Hits $50 Million Start-up Funding Goal
The Indiana Biosciences Research Institute announced today that it has reached the first $50 million funding milestone, fueling continued momentum in the development of the nation’s first industry-led...
> more

November19

Roche to sponsor clinical chemistry fellowship at UC San Diego School of Medicine
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Diagnostics division will provide an educational grant that will be used to sponsor a Clinical Chemistry Postdoctoral Fellowship at the Univ...
> more

November13

Roche to showcase automated molecular and tissue diagnostics technology, next-gen sequencing at AMP 2013 Annual Meeting
Roche (SIX: RO, ROG; OTCQX: RHHBY) will exhibit a diverse portfolio of molecular technology for clinical diagnostic applications and life science research in booth #507 at the Association for Molecula...
> more

July30

Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automa...
> more

July08

Roche submits filing to FDA for cervical cancer primary screening indication for cobas® HPV Test
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has submitted a Premarket Approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) seeking the addition of a cervical cancer prima...
> more

July1

Roche Diagnostics ranked #1 in overall service performance in independent survey of U.S. clinical laboratories
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its U.S. Diagnostics unit was ranked number one in overall service performance by clinical laboratories in the 2013 ServiceTrak™ Clinical Report...
> more

June26

FDA approves new streamlined workflow option for Roche’s cobas HPV Test
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a new, more efficient workflow process for the cobas HPV Test, allowing sample processi...
> more

May23

FDA allows marketing of first A1c test labeled for diagnosing diabetes
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health...
> more

May23

FDA approves Tarceva (erlotinib) tablets and cobas EGFR Mutation Test for specific type of lung cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Tarceva (erlotinib) tablets for the initial (first-line) treatment of people with metas...
> more

March6

FDA approves new Roche test to evaluate response to hepatitis C therapy Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the US Food and Drug Administration (FDA) for a next-generation viral load test to be used in the management of pa...
> more

January17

Roche Diagnostics Named to FORTUNE magazine’s 2013 list of “100 Best Companies to Work For”
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche Diagnostics Corporation has been selected to FORTUNE magazine’s annual list of the “100 Best Companies to Work For.” Roche debuted at 89 o...
> more

 2012

November12

Roche launches additional test for improved management of epithelial ovarian cancer patients
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. market availability of the Elecsys HE4 assay, an FDA approved test used in monitoring patients with ovarian cancer. The HE4 test is used as ...
> more

November6

Roche launches new Light Cycler 96 System enabling broad application of its highperformance PCR technology in academic research
Today Roche announced the global launch of its new LightCycler 96 System, which completes its portfolio of Real Time PCR instruments for life science research. The system’s unique combination of innov...
> more

October24

Roche to showcase molecular technology, next-gen sequencing at 2012 AMP Meeting
Roche (SIX: RO, ROG; OTCQX: RHHBY) will exhibit a diverse portfolio of molecular technology for clinical diagnostic applications and life science research in booth #908 at the Association for Molecula...
> more

October16

FDA clears ACCU-CHEK Inform II, Roche’s new hospital point-of-care system for blood glucose testing with improved accuracy and wireless data transfer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the ACCU-CHEK Inform II system, a next-generation blood glucose m...
> more

October3

Roche’s new dual-target HIV-1 viral load test now available in US
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company’s proprietary dual-target approach. The COBAS TaqMan HIV-1 Test v2.0 for us...
> more

October1

FDA grants CLIA-waived status to CoaguChek XS Plus system for PT/INR testing at the point of care
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation mon...
> more

Sep17

Roche cytomegalovirus viral load test now available in US
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of a new test to assess a patient’s viral load of cytomegalovirus (CMV). Physicians use information from the test to help...
> more

September4

Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assa...
> more

July25

FDA clears Roche’s vitamin D laboratory test
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated vitamin D test for use on cobas® modular platfo...
> more

July16

Roche introduces mobile blood gas analyzer for hospital point of care
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas b 123 POC system, a mobile blood gas analyzer designed for hospital point-of-care settings. The system’s next-gene...
> more

July5

Roche receives FDA approval for Cytomegalovirus viral load test
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for a new test to assess a patient’s viral load of cyt...
> more

June27

Roche introduces cobas p 312 pre-analytical system as compact, front-end automation solution for sample management in US and Canada
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch in the U.S. and Canada of the cobas p 312 pre-analytical system, a front-end automation solution that offers comprehensive, vendor-neutral...
> more

May21

Roche and Indiana Blood Center Announce High School Scholarship Recipients
INDIANAPOLIS (May 21, 2012) – Roche Diagnostics is recognizing 87 high school seniors from across the state who participated in two Indiana Blood Center blood drives during the academic year and showe...
> more

March30

Roche receives FDA approval for cobas p 630 pre-analytical solution for automated molecular testing platform
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molec...
> more

March23

New Professional Guidelines Recognize Benefit of Genotyping HPV 16 and 18 for Cervical Cancer Prevention by Assessing Individual Patient Risk
Roche (SIX: RO, ROG; OTCQX: RHHBY) today welcomed new guidelines for the prevention and early detection of cervical cancer issued jointly by the American Cancer Society (ACS), the American Society for...
> more

March5

Roche, Six Feet Up employees team up to deliver innovation overnight via “Innovation Day” event
Roche Diagnostics announced today that staff from its North American headquarters in Indianapolis teamed up with local web application developer Six Feet Up recently for a 24-hour burst...
> more

February1

Roche receives FDA clearance for test to screen and diagnose chlamydia and gonorrhea infection in symptomatic and asymptomatic patients
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (C...
> more

January26

Roche enters strategic alliance with Technoclone to expand reagent portfolio
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a strategic alliance...
> more

January16

Roche and Indiana Blood Center Partner for High School Scholarship Program
INDIANAPOLIS (January 16, 2012) – Roche Diagnostics and Indiana Blood Center have teamed up to create a $70,000 scholarship program for seniors in 174 high schools throughout the state who host blood ...
> more

 2011

December5

Roche, ChanTest collaborate for preclinical cardiac safety testing of drug
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a collaborative agreement with ChanTest Corporation, a leading ion channel screening provider, to perform cardiac safety tes...
> more

December5

Roche acquires Verum Diagnostica GmbH as part of plan to develop comprehensive coagulation testing portfolio for diagnostic laboratories
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a l...
> more

December5

Roche submits total Vitamin D assay to FDA for clearance on cobas immunoassay and Elecsys analyzers
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated, total vitamin D assay (25-hydroxyvitamin ...
> more

November21

Roche Diagnostics, Cedars-Sinai Medical Center enter strategic alliance for
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the establishment of a strategic alliance with Cedars-Sinai Medical Center in Los Angeles for the center to operate as a Roche Molecular Center of Ex...
> more

November18

FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer
U.S. Food and Drug Administration (FDA) Commissioner revokes approval of Avastin for treatment of metastatic breast cancer (mBC) in the United States. This action concludes the FDA’s review of Avastin...
> more

October31

Roche receives FDA approval for accute hepatitis B test Elecsys Anti-HBc IgM assay completes acute hepatitis test panel on cobas e 601 analyzer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration......
> more

October24

Roche to expand coagulation testing portfolio, develop new systems for diagnostic laboratories in US and Canada by 2014
Comprehensive portfolio for hospital and reference labs will complement existing products for patient self-testing and point-of-care testing by healthcare professionals...
> more

October12

Roche Diagnostics introduces ultra compact LightCycler Nano real-time PCR system in US
Small platform supporting state-of-the-art technology for fast PCR protocols introduced at American Society of Human Genetics meeting in Montreal......
> more

September15

Business Partnership Offers Opportunity to Better Prepare Citizens for Disasters
Indianapolis –Director of Public Safety Frank G. Straub joined the Division of Homeland Security Chief Gary Coons and Tom Adkins, Head of Roche...
> more

July26

Roche Diagnostics showcases new technology at Clinical Lab Expo - Laboratory solutions designed to help improve productivity, enhance patient care
ATLANTA—Roche is featuring a diverse portfolio of diagnostics testing solutions for healthcare professionals in booth #2205 at the AACC/CSCC 2011 Clinical Lab Expo here, July 26-29....
> more

July26

Roche submits acute hepatitis B test to FDA for premarket approval
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has submitted a Premarket Approval Application (PMA)…...
> more

May23

Florida Hospital first U.S. site to adopt new automated laboratory solution from Roche
Florida Hospital is improving its laboratory testing capabilities with new state-of-the-art equipment from Roche Diagnostics that is designed to help labs increase their testing capacity and deliver r...
> more

April29

KIB and Roche plant trees on the near Eastside as part of the 2012 by 2012 initiative 200 trees will add to the landscape of Brookside Park
INDIANAPOLIS – (April 29, 2011) - Keep Indianapolis Beautiful, Inc. (KIB) and more than 200 Roche Diagnostics employees will plant a variety of 200 Indiana native trees in Brookside Park on May 6, as ...
> more

April18

Roche launches EMR interface for VA to facilitate diabetes management
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a new Electronic Medical Record (EMR) interface for the U.S. Department of Veterans Affairs (VA) that helps VA healthcare faci...
> more

April6

MIT’s Koch Institute to use Roche LightCycler 480 system to help advance cancer research
Roche announced that the David H. Koch Institute for Integrative Cancer Research at MIT will be using......
> more

March15

Roche acquires PVT to strengthen laboratory automation in clinical diagnostics
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of PVT Probenverteiltechnik GmbH based in Waiblingen, Germany and of PVT Lab Systems, LLC based in Atlanta, Georgia, USA. PVT is a gl...
> more

March1

Roche CEO will ride to stop diabetes at Indiana Tour de Cure
Roche Diagnostics Chief Executive Officer Jack Phillips has committed to ride in the Indiana Tour de Cure® cycling......
> more

February23

Roche teams with Womack Army Medical Center to become first IVD manufacturer approved for remote network connectivity with DOD
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S. Department of Defense (DOD) to provide remote service and support for its lab analyzers at Womack Army Me...
> more

February3

Roche Diagnostics lights up campus in support of American Heart Association and American Heart Month
INDIANAPOLIS — In conjunction with American Heart Month, Roche Diagnostics North America, headquartered in Indianapolis, will demonstrate its commitment to the American Heart Association (AHA) in ways...
> more

 2010

November15

NT-proBNP guided therapy keeps heart failure patients out of the hospital through a reduction in cardiovascular events
At this year’s congress of the American Heart Association (AHA) in Chicago......
> more

September28

Roche Diagnostics supports fight against MRSA as a sponsor of annual World MRSA Day
Second annual World MRSA Day held to pay tribute to patients and families......
> more

September16

Roche Diagnostics introduces full line of 9-minute STAT assays for cardiac biomarker testing on cobas 6000 analyzer series
INDIANAPOLIS – Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas® 6000 analyzer s...
> more

September13

Roche receives FDA clearance for U.S. launch of cobas 8000 modular analyzer series for high-volume laboratory testing
Flexible “Intelligent LabPower” system helps labs increase efficiency, lets them reconfigure modules for changing......
> more

July26

Roche receives FDA clearance for CoaguChek XS Pro system with bar code reader for PT/INR testing at the point of care
Built-in scanner automatically captures bar-coded operator and patient ID information to help save time......
> more

May14

Roche Diagnostics to hold idea exchange forum for laboratory customers in Indianapolis for first time
SmartLab 2010 will bring healthcare industry thought leaders, diagnostic lab managers to Roche......
> more

February26

Roche Diagnostics introduces lower GPO prices, new tiered pricing structure for ACCU-CHEK Safe-T-Pro and Safe-T-Pro Plus lancets
GPO customers that sign new or extended contract, commit to buy just one case per year qualify for discounts......
> more